Thursday, 20 July 2017

Complex Treatment of Multiple Sclerosis Patients by Use of Fetal Stem Cells

Multiple Sclerosis (MS) is a chronic inflammatory disease of the Central Nervous System (CNS) ultimately leading to demyelination and axonal loss. This disease is complex andmultifactorial, but it seems that the main etiopathogenic event is presented by an aberrant response of the cells of immune system (T and B lymphocytes) to myelin proteins.

Multiple Sclerosis
Three forms of MS disease evolution exist. Approximately 80% of the patients have a Relapsing Remitting Multiple Sclerosis (RRMS) form; two thirds of them can likely develop a secondary progressive form over 10-15 years starting from MS disease onset. Around 20% of the patients can develop a progressive form of MS right from very onset, and such a disease is called Primary Progressive Multiple Sclerosis (PPMS). An average age of the patients with MS disease who were studied assembles 30 years. The main peak of morbidity due to MS can be attributed to the age of 20-40 years. Disease onset in the age of patients up to 16 years constitutes about 2.7% of cases. Read more>>>>>>>

No comments:

Post a Comment